Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P11021 (
BiP
)
2,049
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
BiP
is a member of the Hsp70 heat shock protein family found in the lumen of the endoplasmic reticulum, that binds to a variety of proteins destined to be secreted.
Substance P
(SP) has been used as a model peptide to study the interaction of
BiP
with protein substrates. SP stimulates
BiP
ATPase activity and forms a stable complex with
BiP
that is dissociated in the presence of levels of ATP > 50 microM. At lower concentrations of ATP, the SP remains bound to
BiP
, and the results are consistent with the view that a
BiP
-ATP complex is initially formed that reacts with SP to form a ternary complex, SP-
BiP
-ATP. Hydrolysis of ATP in this complex yields a SP-
BiP
-ADP complex. An exchange of ATP with ADP bound to
BiP
has also been demonstrated, and the results suggest that the interactions of
BiP
with ATP resemble those seen with GTP-binding proteins and GTP.
...
PMID:Similarity of nucleotide interactions of BiP and GTP-binding proteins. 752 51
In the present study, we have used a non-denaturing gel electrophoresis assay to characterize the specificity of the peptide-induced depolymerization process of the isolated recombinant C-terminal domain (C30) of the molecular chaperone
BiP
, in the presence of specific synthetic peptides and with the neuropeptide
Substance P
. In the absence of peptidic ligand, C30 self-associates readily into multiple oligomeric species. Upon peptide addition, C30 oligomers convert into dimers, then into monomers. Our data indicate that the algorithm we previously developed to predict putative
BiP
binding sites in any protein sequence is also a good indicator as to whether a peptide can efficiently induce depolymerization of the C-terminal peptide binding domain and stimulate the ATPase activity of the full-length protein.
...
PMID:Specificity of peptide-induced depolymerization of the recombinant carboxy-terminal fragment of BiP/GRP78. 1048 74
The limitations to high-level expression of integral membrane proteins are not well understood. The human A(2)a adenosine receptor (A(2)a) and mouse
Substance P
receptor (SPR) were individually expressed in S. cerevisiae to identify potential cellular bottlenecks for G-protein coupled receptors. In the yeast system, A(2)a was not N-linked glycosylated but was functional and plasma membrane-localized. A(2)a also contained an intramolecular disulfide bond.
Substance P
receptor was also not N-linked glycosylated in yeast, but, unlike A(2)a, SPR was intracellularly retained, nonfunctional, and did not appear to contain an intramolecular disulfide bond. Since both receptors contain N-linked glycosylation and disulfide bonds in mammalian systems, machinery responsible for interacting with these modifications was investigated-specifically, the potential interactions between the nascent receptor and ER-resident proteins were explored. The chaperones calnexin and protein disulfide isomerase were co-overexpressed with the GPCRs to determine the effect on total and active yields of A(2)a and SPR, as well as on receptor trafficking. The effect of co-expressing the chaperone
BiP
on the total yields of A(2)a as well as intracellular fates of both receptors were determined. The co-expression of ER resident proteins did not improve A(2)a yields nor did they restore SPR activity or improve SPR cell surface expression. Taken together, these results indicate that an ER-folding bottleneck does not limit the expression of the mammalian receptors in yeast.
...
PMID:Co-expression of molecular chaperones does not improve the heterologous expression of mammalian G-protein coupled receptor expression in yeast. 1296 83